Eating Disorders: Clinical Trials

5 trials for Eating Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1

Follow Eating Disorders: new trials by email Literature Review of Eating Disorders trials Research Report on Eating Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa
Food Exposure Therapy and Ritual Prevention with Motivational Enhancement for Relapse Prevention in Anorexia Nervosa (AN-EX/RP), Cognitive behavioral therapy (CBT) - Eating Disorders
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute342007-12-012012-05-11
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
Recombinant Human Growth Hormone, Placebo for Recombinant Human Growth Hormone - Anorexia Nervosa, Osteopenia
Phase 2CompletedMassachusetts General Hospital212006-01-012020-09-02
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
Olanzapine, Placebo - Eating Disorders
Phase 2CompletedNew York State Psychiatric Institute232005-10-012019-05-10
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
Erythromycin, Placebo - Bulimia Nervosa, Eating Disorders
Phase 2CompletedNew York State Psychiatric Institute292004-09-012018-08-20
Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents
Family therapy (FT), Individual therapy (IT) - Eating Disorders
Phase 2CompletedUniversity of Chicago1212004-04-012016-06-20

Narrower conditions

Feeding and Eating Disorders (5)  ·  Anorexia Nervosa (4)  ·  Anorexia (1)  ·  Binge-Eating Disorder (1)  ·  Bone Diseases, Metabolic (1)  ·  Bulimia Nervosa (1)  ·  Osteoporosis (1)

Broader conditions

Mental Disorders (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Signs and Symptoms, Digestive (5)  ·  Bone Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Cognitive Behavioral Therapy (1)  ·  Erythromycin (1)  ·  Family Therapy (1)  ·  Growth Hormone (1)  ·  Olanzapine (1)  ·  Secondary Prevention (1)  ·  methylcobalamin-coenzyme M methyltransferase (1)

Sponsors

New York State Psychiatric Institute (3)  ·  Massachusetts General Hospital (1)  ·  University of Chicago (1)

Countries

United States (5)

Top investigators

Anne Klibanski, MD (1)  ·  B. T. Walsh, MD (1)  ·  Daniel Le Grange, PhD (1)  ·  Evelyn Attia, MD (1)  ·  Joanna E. Steinglass, MD (1)

Results publications

PMID 20570701, PMID 21426603, PMID 24488838

NIH funding

R01MH042206 (1), R01MH070620 (1), R01MH082736 (1), R21MH069868 (1)